# SpyGlass Pharma, Inc.: Form 8-K, filed Feb 13, 2026

- Company: [SpyGlass Pharma, Inc.](/companies/sgp.md) (CIK 1778922)
- Form: 8-K
- Filed: 2026-02-13
- Accepted by EDGAR: Feb 13, 2026, 21:01 ET
- Period: 2026-02-12
- Accession: 0001628280-26-008073
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1778922/000162828026008073/spyglass-form8xk502fx2025c.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1778922/000162828026008073/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1778922/000162828026008073/spyglass-form8xk502fx2025c.htm

Filed Feb 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-008073. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.